MaxCyte MXCT Business Segments
| FY'25 | FY'24 | ||
|---|---|---|---|
| Revenue by Product | |||
| Assay And Other Service Revenue | $1.97M— | —— | |
| License | $12.37M-24.6% | $16.41M— | |
| Revenue by Geography | |||
| Non Us | $11.95M-7.1% | $12.86M+45.0% | |
| US | $21.08M-18.2% | $25.77M-20.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does MaxCyte break its business down?
- MaxCyte (MXCT) reports revenue by product across 2 parts — Assay And Other Service Revenue and License. Each is extracted from the segment footnotes and tracked over time.
- Where does MaxCyte's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in MaxCyte's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
